+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
530207 BRAWN

Brawn Biotech Share Price

 

 

Brawn Biotech live price: ₹21.02. It opened at ₹22 vs previous close ₹22; intraday high/low: ₹22/₹21. The 50 & 200 DMA stand at ₹20.72/₹20.41.

Brawn Biotech Performance

  • Today's Low
  • ₹21
  • Today's High
  • ₹22
  • 52 Week Low
  • ₹17
  • 52 Week High
  • ₹24
  • Open Price₹22
  • Previous Close₹22
  • Volume1,652
  • 50 DMA₹20.72
  • 100 DMA₹20.62
  • 200 DMA₹20.41

Brawn Biotech Chart

Investment Returns

  • Over 1 Month + 10.34%
  • Over 3 Month + 2.64%
  • Over 6 Month -8.57%
  • Over 1 Year + 9.65%

Smart Investing Starts Here Start SIP with Brawn Biotech for Steady Growth!

Invest Now

Brawn Biotech Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 6.7
  • PEG Ratio
  • 0
  • Market Cap Cr
  • 6
  • P/B Ratio
  • 1.5
  • Average True Range
  • 0.81
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • 0.12
  • RSI
  • 51.16
  • MFI
  • 53.77

Brawn Biotech Financials

Brawn Biotech Technicals

EMA & SMA

Current Price
₹21.02
-0.98 (-4.45%)
pointer
  • Bearish Moving Average 4
  • Bullish Moving Average 12
  • 20 Day
  • ₹20.90
  • 50 Day
  • ₹20.70
  • 100 Day
  • ₹20.60
  • 200 Day
  • ₹20.40

Resistance and Support

21.35 Pivot Speed
  • R3 22.65
  • R2 22.33
  • R1 21.67
  • S1 20.69
  • S2 20.37
  • S3 19.71

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Brawn Biotech has an operating revenue of Rs. 16.98 Cr. on a trailing 12-month basis. An annual revenue growth of 29% is outstanding, Pre-tax margin of 0% needs improvement, ROE of 21% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. It is currently FORMING a base in its weekly chart and is trading around 9% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 64 which is a FAIR score but needs to improve its earnings, a RS Rating of 68 which is FAIR indicating the recent price performance, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 36 indicates it belongs to a strong industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Institutional holding has remained stable in the last reported quarter. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Brawn Biotech Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-29 Audited Results
2025-11-14 Quarterly Results
2025-08-13 Quarterly Results
2025-05-26 Audited Results
2025-02-12 Quarterly Results

Brawn Biotech Shareholding Pattern

52.94%
0.35%
0%
0%
0%
30.53%
16.18%

Brawn Biotech FAQs

Brawn Biotech share price is ₹21 As on 12 July, 2026 | 17:51

The Market Cap of Brawn Biotech is ₹6.3 Cr As on 12 July, 2026 | 17:51

The P/E ratio of Brawn Biotech is 6.7 As on 12 July, 2026 | 17:51

The PB ratio of Brawn Biotech is 1.5 As on 12 July, 2026 | 17:51

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23